Skip to market wire
Back to Market返回行情

GSK.L GSK plc

LSEHealthcare
$1,881.00-2.06%ClosedMarket Cap: $75.37B

As of 2026-08-21 06:37

Why GSK.L matters now

GSK plc (GSK.L) is a US stock in Healthcare. The latest InvestLog snapshot shows $1,881.00 with -2.06% on the session and $75.37B in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 15.67, gross margin 73.3%, and operating margin 24.1%.

The latest indexable market news headline is "GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth" from Proactive Investors - Finance.

Valuation

P/E (TTM)

15.67

PEG

P/B

4.28

P/S

2.27

EV/EBITDA

8.26

DCF Value

FCF Yield

7.6%

Div Yield

3.6%

Margins & Returns

Gross Margin

73.3%

Operating Margin

24.1%

Net Margin

14.5%

ROE

28.3%

ROA

7.8%

ROIC

16.0%

Listing Info

Market

US

Exchange

LSE

Currency

USD

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

GB

GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.